Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lipitor Generics Problem Illustrates Need For Hatch-Waxman Reform, Academics Say

This article was originally published in The Pink Sheet Daily

Executive Summary

Even with revised use-it-or-lose it provisions, exclusivity parking is still prevalent and won't be prevented by banning "pay-for-delay" settlements, David Balto and Michael Carrier argue.

You may also be interested in...



Brand-Generic "Pay-For-Delay" Settlements Jump 63% In FY 2010

As a proportion of total settlements reported to FTC, however, the ones involving compensation to the generic firm remained the same.

Brand-Generic "Pay-For-Delay" Settlements Jump 63% In FY 2010

As a proportion of total settlements reported to FTC, however, the ones involving compensation to the generic firm remained the same.

Lipitor Generics: FDA Says Mylan Has No Standing To Sue (Until June 28?)

FDA is using a recent court decision involving ViroPharma’s antibiotic Vancocin to argue for dismissal of a Mylan Pharmaceuticals Inc. lawsuit that seeks a determination on generic marketing exclusivity rights for Pfizer’s Lipitor.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS072154

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel